Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001846253-23-000010
Filing Date
2023-02-01
Accepted
2023-02-01 14:28:20
Documents
1
Period of Report
2023-01-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5515
  Complete submission text file 0001846253-23-000010.txt   7058
Mailing Address 5980 HORTON STREET SUITE 600 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 600 EMERYVILLE CA 94608 510-250-7800
OmniAb, Inc. (Issuer) CIK: 0001846253 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O LIGAND PHARMACEUTICALS INC 3911 SORRENTO VALLEY BOULEVARD, STE 100 SAN DIEGO CA 92121
Business Address
Cochran Jennifer R. (Reporting) CIK: 0001872349 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40720 | Film No.: 23576137